High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Strong Balance Sheet.
Profitability: Very strong Profitability. One year profit margin are 17%.
Past Returns: In past three years, the stock has provided 13% return compared to 8.8% by NIFTY 50.
Size: Market Cap wise it is among the top 20% companies of india.
Growth: Awesome revenue growth! Revenue grew 36.7% over last year and 71.1% in last three years on TTM basis.
Smart Money: Smart money has been increasing their position in the stock.
Technicals: SharesGuru indicator is Bearish.
Valuation | |
|---|---|
| Market Cap | 31.58 kCr |
| Price/Earnings (Trailing) | 57.05 |
| Price/Sales (Trailing) | 10.07 |
| EV/EBITDA | 33.4 |
| Price/Free Cashflow | 2.68 K |
| MarketCap/EBT | 43.99 |
| Enterprise Value | 32.67 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 3.14 kCr |
| Rev. Growth (Yr) | 47.2% |
| Earnings (TTM) | 545.89 Cr |
| Earnings Growth (Yr) | 121.8% |
Profitability | |
|---|---|
| Operating Margin | 24% |
| EBT Margin | 23% |
| Return on Equity | 15.16% |
| Return on Assets | 9.67% |
| Free Cashflow Yield | 0.04% |
Growth & Returns | |
|---|---|
| Price Change 1W | 4.7% |
| Price Change 1M | -1.5% |
| Price Change 6M | 33.1% |
| Price Change 1Y | 46.4% |
| 3Y Cumulative Return | 13% |
| 5Y Cumulative Return | 17.5% |
| 7Y Cumulative Return | 36% |
| 10Y Cumulative Return | 33.6% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -511.07 Cr |
| Cash Flow from Operations (TTM) | 570.81 Cr |
| Cash Flow from Financing (TTM) | -46.7 Cr |
| Cash & Equivalents | 49.18 Cr |
| Free Cash Flow (TTM) | 9.67 Cr |
| Free Cash Flow/Share (TTM) | 1.89 |
Balance Sheet | |
|---|---|
| Total Assets | 5.64 kCr |
| Total Liabilities | 2.04 kCr |
| Shareholder Equity | 3.6 kCr |
| Current Assets | 2.11 kCr |
| Current Liabilities | 767.67 Cr |
| Net PPE | 2.63 kCr |
| Inventory | 357.95 Cr |
| Goodwill | 87.76 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.2 |
| Debt/Equity | 0.32 |
| Interest Coverage | 5.13 |
| Interest/Cashflow Ops | 7.16 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 13.5 |
| Dividend Yield | 0.22% |
| Shares Dilution (1Y) | 3.3% |
| Shares Dilution (3Y) | 3.4% |
Balance Sheet: Strong Balance Sheet.
Profitability: Very strong Profitability. One year profit margin are 17%.
Past Returns: In past three years, the stock has provided 13% return compared to 8.8% by NIFTY 50.
Size: Market Cap wise it is among the top 20% companies of india.
Growth: Awesome revenue growth! Revenue grew 36.7% over last year and 71.1% in last three years on TTM basis.
Smart Money: Smart money has been increasing their position in the stock.
Technicals: SharesGuru indicator is Bearish.
Investor Care | |
|---|---|
| Dividend Yield | 0.22% |
| Dividend/Share (TTM) | 13.5 |
| Shares Dilution (1Y) | 3.3% |
| Earnings/Share (TTM) | 108.02 |
Financial Health | |
|---|---|
| Current Ratio | 2.75 |
| Debt/Equity | 0.32 |
Technical Indicators | |
|---|---|
| RSI (14d) | 38 |
| RSI (5d) | 43.44 |
| RSI (21d) | 41.03 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Sell |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Buy |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of Navin Fluorine International's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
The management of Navin Fluorine International Limited provided a positive outlook during the earnings call for Q3 and the nine-month period ending December 31, 2025. Key highlights include a robust 44% increase in revenue year-on-year, reaching INR 2,376 crores, with quarterly revenues rising by 47% to INR 892 crores. The EBITDA margins improved significantly to 32% from 21.5% in the previous year.
Major forward-looking points mentioned by management include:
Successful commissioning of the cGMP-4 Phase-1 facility, with commercial supplies beginning after validation, is expected to enhance revenue streams significantly.
The AHF project has also been commissioned, leading to commercial supplies starting recently. This project is expected to bolster the specialty chemicals segment, showcased by a 60% revenue increase in this division to INR 354 crores.
Management anticipates ongoing capacity expansions will sustain growth in the HPP business, which saw a revenue increase of 35% year-on-year to INR 412 crores.
The CDMO business reported strong momentum with a 61% increase in revenue to INR 127 crores. A partnership with a major European client is expected to yield significant revenue visibility over the next three years.
The government's focus on domestic manufacturing, especially with initiatives like the Semiconductor Mission 2.0, is viewed positively, providing new opportunities for the company in the advanced materials sector.
All ongoing capital expenditures (CAPEX) are progressing well. An additional CAPEX aimed at increasing HFC production capacity is expected to be commissioned by Q3 FY27.
In summary, management is optimistic about sustained growth across all business segments, supported by favorable macroeconomic trends and a strong project pipeline.
1. Question from Sanjesh Jain: "Navin Fluorine Advanced Sciences appears to be doing significantly better sequentially; what segment is driving such a sharp improvement? Where are we in the utilization cycle for all the projects?"
Answer: I confirm the solid sequential growth largely stems from our specialty vertical projects, particularly the Nectar ramp-up. We expect to hit par utilization for MPP-1, MPP-2 is at about 70-80%, and Nectar should reach approximately 50% this year. The dedicated plant is also around 70% utilized. There's potential for further growth, particularly with the commissioning of the AHF project and the de-bottlenecking initiative.
2. Question from Nitesh: "Has there been a change in the exports to domestic mix on the R-32 side, and how much has been R-32 utilization in Q3?"
Answer: R-32 utilization was at 100%. While we've planned a shutdown for catalyst changeover, the export-domestic mix hasn't materially changed. We are expanding market reach as we prepare for new capacity and exploring more global access for R-32.
3. Question from Jason: "How much of the 40,000 AHF capacity will be used captively and how much will be sold externally?"
Answer: The strategy focuses on increasing captive consumption to enhance realizations. The goal is to tap niche chemistries and advanced applications with the additional capacity. We haven't set specific proportions yet, as this capacity serves as a growth catalyst for various downstream opportunities.
4. Question from Rohit: "Are we on track to utilize the other half of the Nectar project capacity in FY27?"
Answer: Yes, we are focused on securing the other half of the Nectar project capacity by FY27. Our goal is to be very close to full utilization, leveraging strong demand in our specialty chemicals sector.
5. Question from Archit Joshi: "What trajectory can we expect for revenue growth in the CDMO segment, especially regarding the MSA with the first EU major?"
Answer: CDMO growth looks promising, driven by significant deal wins. We have a balanced portfolio with a 50-50 split of early and late-stage molecules, which positions us well for revenue conversions. With continuous product extensions from our EU major partner, we are inching toward our $100 million target.
Each answer indicates our strategies, operational status, and forward-looking potential across various sectors.
Understand Navin Fluorine International ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| MAFATLAL IMPEX PRIVATE LIMITED (Mafatlal Exim Pvt Ltd amalgamated with Mafatlal Impex Pvt Ltd) | 25.44% |
| QUALIFIED INSTITUTIONAL BUYER | 8.99% |
| LIFE INSURANCE CORPORATION OF INDIA | 6.43% |
| SBI MUTUAL FUNDS | 3.8% |
| GOVERNMENT PENSION FUND GLOBAL | 3.57% |
| AXIS MUTUAL FUND TRUSTEE LIMITED | 2.37% |
| KOTAK FUNDS - INDIA MIDCAP FUND | 1.37% |
| EDELWEISS MUTUAL FUNDS | 1.31% |
| GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY | 1.29% |
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED | 1.28% |
| NIPPON LIFE INDIA TRUSTEE LTD | 1.24% |
| ABU DHABI INVESTMENT AUTHORITY | 1.23% |
| AJAY UPADHYAYA | 1.01% |
| VISHAD MAFATLAL AS TRUSTEE OF VISHAD P MAFATLAL FAMILY TRUST NO. 1 | 0.75% |
| VISHAD PADMANABH MAFATLAL | 0.64% |
| VISHAD PADMANABH MAFATLAL PUBLIC CHARITABLE TRUST NO. 1 | 0.24% |
| PADMANABH ARVIND MAFATLAL (HUF) | 0.03% |
| VISHAD P. MAFATLAL PAM HUF1 P MAFATLAL | 0.01% |
| PAMIL INVESTMENTS PVT LTD | 0.01% |
| TEREBINTH VENTURES PRIVATE LIMITED (formerly known as Anshi Ventures Private Limited) | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Navin Fluorine International against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND | Pidilite Industries | 1.31 LCr | 14.44 kCr | -13.80% | -9.50% | 57.09 | 9.06 | - | - |
| SRF | SRF | 72.27 kCr | 15.6 kCr | -4.80% | -17.00% | 40.61 | 4.63 | - | - |
| FLUOROCHEM | Gujarat Fluorochemicals | 33.27 kCr | 4.91 kCr | -13.10% | -24.70% | 50.69 | 6.77 | - | - |
| AARTIIND | Aarti Industries | 14.46 kCr | 8.05 kCr | -10.80% | +2.10% | 51.33 | 1.8 | - | - |
| GALAXYSURF | Galaxy Surfactants | 5.37 kCr | 5.11 kCr | -22.80% | -26.10% | 19.12 | 1.05 | - | - |
Comprehensive comparison against sector averages
NAVINFLUOR metrics compared to Chemicals
| Category | NAVINFLUOR | Chemicals |
|---|---|---|
| PE | 57.08 | 39.59 |
| PS | 10.07 | 3.67 |
| Growth | 36.7 % | 4.8 % |
Navin Fluorine International Limited manufactures and sells specialty fluorochemicals in India and internationally. The company offers refrigerants for various applications, including window and split room air conditioners, chillers, packaged air conditioners, commercial and industrial refrigeration units, intermediate for active pharmaceutical ingredient, fluoropolymer resins, domestic and industrial refrigerators, and mobile air conditioning under the Mafron brand for original equipment manufacturer, service technicians, and equipment owners. It provides inorganic fluoride products, such as ammonium bifluoride, potassium fluoride, sodium fluoride, potassium fluorotitanate, potassium fluoroborate, hexafluorophosphoric acid, and hydrofluo pyridine and hydrofluo urea complex products for oil and gas, stainless steel, pharmaceutical and agrochemicals, abrasives, electronics, and solar energy industries. In addition, the company offers various specialty fluoro intermediates consisting of boron trifluoride gas and adducts for pharmaceutical industry, as well as crop protection, hydrocarbon, and fragrance applications; and contract development and contract manufacturing services comprising basic research, library syntheses, process development, scale up, and batch manufacturing for custom chemical syntheses of fluorinated compounds in the pharmaceuticals, agro chemicals, and specialty chemicals industries. Navin Fluorine International Limited was founded in 1967 and is headquartered in Mumbai, India.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
NAVINFLUOR vs Chemicals (2021 - 2026)